Home/Industry News/FSD Pharma ‘hunkering down’ on grow facility and ‘doubling down’ on biosciences effort
FSD Pharma ‘hunkering down’ on grow facility and ‘doubling down’ on biosciences effort
investmentvaluefinders 9 December, 2019Industry NewsComments Off on FSD Pharma ‘hunkering down’ on grow facility and ‘doubling down’ on biosciences effort1,317 Views
FSD Pharma Inc (CSE:HUGE) (OTCMKTS:FSDDF) CEO Raza Bokhari reveals 3Q highlights for the medically-focused cannabis company.
Bokhari says the Canadian company is ‘hunkering down’ on its cannabis grow facility and ‘doubling down’ on its biosciences effort, advancing its Phase 1 safety trials for its lead drug candidate PP 101 micro-PEA.
Investment Value Finders specializes in providing opinions and information on stocks to individuals who wish to receive them. Our reports are construed for information purposes solely and are distributed free of charge to individuals who wish to receive them.
Investment Value Finders does not promote, condone or advocate licit or illicit drug use. Investment Value Finders cannot be held responsible for materials or contests posted on its website pages, or pages to which we provide links, which promote, condone or advocate licit or illicit drug use or illegal activities.
DO NOT BASE ANY INVESTMENT DECISION UPON ANY MATERIALS FOUND ON THIS WEBSITE. We are not registered as a securities broker-dealer or an investment adviser. We are neither licensed nor qualified to provide investment advice.
Investment Value Finders occasionally receives direct compensation for hosting links (or other* advertisements) to third party content that may be subject to disclaimer pursuant to Section 17(b) of the Securities Act of 1933. For those instances where the link text contains company or stock-specific mention, we provide the following list of compensation received in order to ensure full disclosure and transparency.
Investment Value Finders is intended for those 21+ years of age only!
Stock markets worldwide have been in red since Russia began its invasion of Ukraine last …
Cookie Policy
This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Read MoreCookie settingsACCEPT
Cookies Policy
Privacy Overview
This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are as essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.